The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
European Journal of Cancer2017Vol. 76, pp. 167–182
Citations Over TimeTop 1% of 2017 papers
Related Papers
- → Indoleamine 2,3-Dioxygenase Does It(2015)3 cited
- → Pharmacological Inhibition of the Immunomodulatory Enzyme Indoleamine 2,3-Dioxygenase (IDO) Cooperatively Leverages Cytotoxic Chemotherapy(2005)
- → ATP promotes immunosuppressive MSCs inhibiting lymphocyte proliferation and expressing indoleamine dioxygenase(2017)
- Screening of the inhibitory activity of Korea local plant extracts against indoleamine 2,3-dioxygenase (IDO) = 한국 자생식물 추출물의 Indoleamine 2,3-dioxygenase (IDO) 저해활성(2011)
- 教15-2 妊娠免疫とIDO (Indoleamine 2, 3-dioxygenase)(アレルギー疾患の発症における免疫・神経・内分泌系のクロストーク,ミニシンポジウム,教育コース15(基礎・その他),第22回日本アレルギー学会春季臨床大会)(2010)